Expertise in
6
conditions

Julie A. Lovshin

Divison Of Endocrinology, Unversity Of Toronto
Toronto, ON, CA 
Expertise in
6
conditions
Divison Of Endocrinology, Unversity Of Toronto
Toronto, ON, CA 

Overview

Julie Lovshin practices practicing medicine in Toronto, Canada.

Ms. Lovshin is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Diabetic Nephropathy, Diabetic Neuropathy, and Maturity Onset Diabetes of the Young.

She is actively involved in clinical research, co-authoring 60 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Divison of Endocrinology, Unversity of Toronto
Toronto, ON, Canada
Other Locations
Toronto, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Effects of DPP-4 Inhibitor Therapy on Renal Sodium Handling and Renal Hemodynamics in Type 2 Diabetes Patients. The INDORSE Study: Inhibition of Dipeptidyl Peptidase IV: Outcomes on Renal Sodium Excretion
Effects of DPP-4 Inhibitor Therapy on Renal Sodium Handling and Renal Hemodynamics in Type 2 Diabetes Patients. The INDORSE Study: Inhibition of Dipeptidyl Peptidase IV: Outcomes on Renal Sodium Excretion
Enrollment Status: Completed
Publish Date: April 05, 2018
Intervention Type: Drug, Other
Study Phase: Phase 4
Clinical Evaluation of Psoriatic Arthritis Treated With Liraglutide. The PLAQUE Study: Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study
Clinical Evaluation of Psoriatic Arthritis Treated With Liraglutide. The PLAQUE Study: Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study
Enrollment Status: Withdrawn
Publish Date: July 17, 2017
Intervention Type: Other, Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

60 Total Publications

Combination Pharmacotherapy in Type 2 Diabetes and Chronic Kidney Disease: Translating Evidence into Clinical Practice.
Combination Pharmacotherapy in Type 2 Diabetes and Chronic Kidney Disease: Translating Evidence into Clinical Practice.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: August 18, 2026

Frequently Asked Questions about Julie A. Lovshin

Is Julie A. Lovshin a top-rated expert for Type 1 Diabetes (T1D)?

MediFind is an objective health platform that identifies experts based on real-world data. Julie A. Lovshin is classified as an Distinguished expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Julie A. Lovshin participate in research or clinical trials?

Yes. Julie A. Lovshin has published 60 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of Julie A. Lovshin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Lovshin's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile